Christopher M. Owens, Managing Director at Lightstone Ventures, Menlo Park, California, United States — verified investor profile. See contact routes.
Lightstone Ventures was founded in 2012 to empower founders to bring innovative therapeutics to patients. They invest in novel, disruptive technologies, breakthrough therapies, and technologies with the potential to be industry-first or industry-leading products. Their focus is on biotech (first-in-class drugs across small molecules, biologics, cell and gene therapies, in CNS, immunology, oncology, ophthalmology) and medtech (personalized medicines, targeted therapeutics leveraging data analytics, in immunology, cardiovascular, neurology, ophthalmology). They invest with a long-term vision and patient capital, spanning all stages of company growth from start-up to commercialization. They operate globally with offices in the U.S. and Ireland, and have a strategic investment in 65LAB, an incubator in Singapore.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Menlo Park.
Investors like Christopher M. Owens · Full investor directory · Investor access · Company funding database